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Abstract
With the increasing need for kidney transplantation in the paediatric population and changing donor demographics, children
without a living donor option will potentially be offered an adult deceased donor transplant of marginal quality. Given the
importance of long-term graft survival for paediatric recipients, consideration is now being given to kidneys from small paediatric
donors (SPDs). There exist a lack of consensus and a reluctance amongst some centres in transplanting SPDs due to high surgical
complication rates, graft loss and concerns regarding low nephron mass and long-term function. The aim of this review is to
examine and present the evidence base regarding the transplantation of these organs. The literature in both the paediatric and adult
renal transplant fields, as well as recent relevant conference proceedings, is reviewed. We discuss the surgical techniques, long-
term graft function and rates of complications following transplantation of SPDs. We compare graft survival of SPDs to adult
deceased donors and consider the use of small paediatric donors after circulatory death (DCD) organs. In conclusion, evidence is
presented that may refute historically held paradigms regarding the transplantation of SPDs in paediatric recipients, thereby
potentially allowing significant expansion of the donor pool.
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Introduction
Inmany countries, rates of living donor renal transplantation
appear to have reached a plateau or have even started to fall.
There were approximately 1050 living kidney donors each
year from 2010 to 2017 in the UK, whilst in the USA there
has been a steady decline from 6279 living kidney donors in
2010 to 5627 donors in 2016 (Table 1) [1, 2]. At the same
time, in the UK, the proportion of adult organs from donors
after circulatory death (DCD) has dramatically increased,
and now accounts for 40% of all deceased donors [1]. With
adult donor demographics changing, the quality of organs
from donors following brain death (DBD) is worsening; do-
nors are typically older, have higher BMIs and possess co-
morbidities such as hypertension and diabetes. In the UK,
the number of deceased donors over the age of 60 years has
risen from 17% in 2007 to 36% in 2016, whilst the number of
donors over the age of 70 years has risen from 3 to 14% over
the same period. Similarly, the proportion of hypertensive
deceased donors rose from 18% in 2003 to 31% in 2012 [3].
The resulting decline in the quality of donor organs has meant
that by 2012 only 1 in 5 of all deceased donors were consid-
ered as ‘ideal’, i.e. aged under 60 years, with a body mass
index (BMI) under 30 kg/m2 and no history of smoking or
hypertension. The implication of changing donor demo-
graphics is that many children in the UK and USA that do
not have a living donor option will be offered an adult de-
ceased donor transplant potentially of marginal quality, de-
spite efforts to match with organs possessing the lowest
Kidney Donor Profile Index (KDPI). Whilst paediatric
Eurotransplant kidneys are prioritised for paediatric recipients,
this has not historically been the case in the UK or the USA
due to concerns regarding technical complications. However,
given the importance of long-term graft survival for paediatric
recipients and recent paradigm shifts within individual units,
consideration is now being given to new sources of organs
which might sustain excellent renal function with longer graft
survival. Attention has therefore turned to the use of organs
from small paediatric donors (SPD).
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The proportion of paediatric transplants in the USA
utilising organs from deceased donors under 10 years old
has declined dramatically from 35% in 1987 to 5% in 2010
[4]. This is only partially accounted for by the increase in live
donation during this time period. A UK registry review of the
use of paediatric donors between 1997 and 2011 identified 17
renal transplants from donors under the age of 2 years old,
with 5 donors under the age of 1 year and no neonatal donors.
Of these organs, 82% were transplanted en bloc into adult
recipients [5]. En bloc refers to retrieving both kidneys and
major blood vessels together, with subsequent anastomoses of
the donor aorta and inferior cava to the recipient vessels [6].
Historically, high vascular and urologic complication rates
had made utilisation of these grafts challenging in both paedi-
atric and adult recipients.
There exist a lack of consensus and a reluctance amongst
centres in transplanting SPD organs due to an increased risk
of thrombosis of the donor vessels. For the purposes of this
review, we have defined a SPD as a donor weighing less than
20 kg, though definitions vary in the literature. An average
child of 20 kg is approximately 6 years old, with a renal
length of approximately 8 cm. A univariate analysis by
Singh et al. of NAPRTCS registry data showed significantly
higher rates of SPD graft loss due to thrombosis in paediatric
recipients under 2 years old compared to those over 12 years
old (9.0 vs 3.5%; p = 0.01). Furthermore, there was a graft
thrombosis rate of 8.3% (n = 386) in organs from donors
under the age of 5 years, compared to 3.2% (n = 1667) in
donors over 10 years [7].
There are concerns that the small nephron mass provided
by small kidneys from SPDs may not provide adequate renal
function in adult recipients with a potential risk of
hyperfiltration-associated renal injury and graft loss.
However, Al-Bader et al.’s retrospective review of paediatric
small kidneys transplanted into adult recipients, when com-
pared to matched adult donors, showed no long-term deterio-
ration in graft function and demonstrated similar creatinine
clearances in both groups at various end points [8].
Due to these concerns, the use of SPD organs in both adult
and paediatric transplantation remains controversial and there-
fore raises questions that should be addressed. What is the
long-term graft function and survival when compared to adult
donor organs? What is the additional risk associated with the
use of SPD organs and how does this compare to organs from
elderly deceased donors? Should small kidneys be used ex-
clusively for paediatric recipients? Should they be implanted
as single kidneys or en bloc? Is there a minimum weight for
the donor? Can we transplant organs from small paediatric
DCDs? Should a paediatric transplant surgeon be present at
the time of retrieval to facilitate organ assessment? If so, is the
extra resource allocation cost and time effective, when the
return is relatively low?
This review article aims to address these points and to
determine if the use of SPD organs are appropriate and under
what circumstances.
Graft survival
Studies examining outcomes following transplantation using
SPDs (with more than 20 recipients) are shown in Table 2 [5,
11–15, 18, 20, 22, 23, 25–28, 30, 31]. In one of the largest
studies to date, a US-based registry analysis of 2449 renal
transplants from paediatric donors under 20 kg [11], the au-
thors demonstrated a 5-year graft survival rate of 55% for
single-organ kidney transplants and 73% for en bloc kidney
(EBK) transplants, with a hazard ratio of 0.96 per 1 kg in-
crease in donor weight for graft loss. These results are com-
parable to those of a large UNOS registry review, which iden-
tified a mean 5-year graft survival rate of 56% in 2198 trans-
plants where the donor’s age was 5 years old or less (p < 0.01)
[12]. This was compared to a 65% graft survival rate in 7767
transplants where the donor’s age was between 12 and
17 years old. The authors also identified a 10% graft throm-
bosis rate in kidneys from donors aged 5 years or under, with
an overall 1-year graft survival of 82% with any paediatric
Table 1 Donor type over the last
8 years in the UK and USA 2010 2011 2012 2013 2014 2015 2016 2017
Living donors, USA 1 6279 5773 5619 5735 5538 5631 5627 5817
Living donors, UK 2 1062 1046 1055 1101 1148 1092 1078 1043
Total deceased donors, USA 1 7241 7434 7421 7548 7763 8250 9116 9401
Total deceased donors, UK 2 959 1010 1088 1212 1320 1282 1364 1413
DCD donors, USA 1 943 1057 1107 1207 1292 1494 1684 1883
DCD donors, UK 2 335 373 436 507 540 510 579 584
Deceased donors under 17 years, USA 1 956 881 852 873 842 939 934 896
Deceased donors under 17 years, UK 2 38 40 44 36 52 51 55 57
DCD donors after circulatory death
1US annual figures are for calendar years; 1 Jan 2016 to 31 Dec 2016 is given as 2016
2UK yearly figures are for financial years; 2009/2010 is given as 2010
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donor, compared with 84% with adult donor organs
(p < 0.01). In a European registry analysis of 429 transplants
from paediatric donors aged between 0 and 5 years into pae-
diatric recipients, the authors sought to examine the associa-
tion of donor-recipient age combination with 5-year graft sur-
vival [14]. Performing sub-group analyses for recipient age
ranges (0–3 years, 0–5 years, 6–11 years and 12–19 years),
they demonstrated 5-year graft survival rates of 70%, 75%,
81% and 83% respectively.
These reports consistently demonstrate good long-term
graft survival but with an increase in the risk of early graft
loss from thrombosis. However, it is important to consider that
a majority of these analyses are historical and there exist no
recent large-scale reviews or randomised controlled trials.
Furthermore, the quality of deceased donor organs and the
use of anti-thrombotic protocols have evolved since this data
was collected.
A number of investigators have sought to compare the
outcomes of SPD kidney transplants to matched cohorts of
adult standard criteria donor (SCD) transplants [17, 22, 23,
28]. In a large retrospective review of a single centre experi-
ence, 100 EBK transplants were compared to adult matched
DBD transplants (mean age 1.8 years vs 42.9 years respec-
tively). Graft survival at 1 year was slightly inferior in the
EBK group (82 vs 88.9% respectively) with a graft thrombosis
rate of 15% in the former [17]. The authors demonstrated
better graft survival in the EBK group compared to the adult
group at 12-year follow-up (78.7 vs 69.2% respectively).
Similarly, Sharma et al. in a retrospective single-centre review
compared outcomes of both EBK and single kidney trans-
plants to an adult cohort of SCD and extended criteria donor
(ECD) transplants [23]. Graft survival at 5 years was signifi-
cantly better within the EBK and single kidney groups (94%
and 81% respectively, p = 0.02) compared to the adult donor
groups, with both SCD and ECD 5-year graft survival at 75%.
However, a small review by Stey et al. demonstrated contrast-
ing findings, with inferior outcomes in the SPD group [22].
The authors in a review from 1992 to 1999 of 56 EBK trans-
plants compared outcomes to adult deceased donor transplants
in the same centre. One-year graft survival was inferior at 78%
compared to 92% in the adult cohort. However, it is important
to note that the graft thrombosis rate was unusually high
(21%) despite the routine use of heparinisation, which may
allude to technical difficulties when carrying out these chal-
lenging procedures.
Despite the historically high technical failure rate associated
with transplantation of SPDs, it appears overall that long-term
outcomes are superior when compared to matched cohorts of
adult SCD grafts. The published outcomes are excellent even
when compared with outcomes following living donor trans-
plantation [20, 23]. Clearly, more data is needed; however, per-
haps the better comparison is with the long-term outcomes
following ECD organ transplantation. There is a paucity of data
available, with only one largeUNOS registry review comparing
graft survival of SPDs and ECDs [10]. Bhayana et al. analysed
3198 SPD transplants, comprising of both EBKs and single
kidney transplants. Graft survival at 1 year was 85% and 81%
respectively and was comparable to ECD 1-year graft survival
of 83%. Graft survival at 10 years was significantly better in the
EBK and single kidney transplant groups compare to that in the
ECD groups (64% + 53% vs 40%). These findings confirm the
role of SPD organs for transplantation with measurably excel-
lent long-term results; however, the next consideration is
whether EBK transplantation might result in better outcomes
by increasing nephron mass and fewer complications by
minimising vascular thrombosis [24].
EBK versus single organ kidney
transplantation
Unsurprisingly, there are currently no randomised controlled
trials comparing outcomes following EBK transplantation to
single kidney transplantation, in part due to the low frequency
of such transplants at centres throughout the world.
Comparison of the techniques is confounded by the fact that
kidneys undergoing en bloc transplantation are typically
smaller with a lower mass than those that may be considered
for single implantation. Furthermore, damage to the en bloc
specimen at retrieval may result in one organ being discarded
and the other organ being transplanted singly. This will likely
increase the risk of complications, reduce nephron mass and
affect long-term survival.
Studies which have attempted to compare EBK and single
kidney transplantation are shown in Table 2. Several small,
single-centre reviews have shown overall excellent outcomes
following both techniques; however, they demonstrate conflict-
ing results as to which technique is superior [18, 23, 24, 26, 29].
The strongest evidence that EBK transplantation might pro-
vide superior graft survival comes from several largeUS registry
reviews [9–11, 15]. In the largest published review of UNOS
registry data available to date, Dharnidharka et al. sought to
examine the outcomes following single kidney and EBK trans-
plantation in 3957 recipients [9]. Graft survival at 1, 3 and
5 years in the single kidney cohort were 81%, 68% and 63%
respectively whilst graft survival in the EBK cohort was 85%,
76% and 71% respectively. EBK transplantation demonstrated
significantly better graft survival at the various follow-up time
points (p < 0.001). The previously described registry review by
Bhayana et al. in 3198 SPD organ recipients demonstrated su-
perior EBK transplantation outcomes at 1 and 10 years (85%
and 64%) compared to single kidney transplantation (81% and
53%) at similar time points [10]. Despite the increased risk of
early graft thrombosis for EBK and single kidney transplanta-
tion (5% and 3% respectively, compared to 1.8% for SCD and
2% for ECD transplantation), SPDs demonstrated excellent
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Table 2 Outcomes after transplantation from SPD kidneys: ranked by n = x
Author Date range n = x Definition of SPD Outcome – graft survival Comments
Dharnidharka [9] 1987–2003 3957 0–5 years 1-year graft survival EBK GT rate 4%
SOK GT rate 3%▪ SOK – 81%
▪ EBK – 85%
3-year graft survival
▪ SOK – 68%
▪ EBK – 76%
5-year graft survival
▪ SOK – 63%
▪ EBK – 71%
Bhayana [10] 1998–2006 3198 0–5 years 1-year graft survival EBK GT rate 5%
SOK GT rate 3%▪ SOK – 81%
▪ EBK – 85%
▪ Adult SCD – 90%
▪ Adult ECD – 83%
10-year graft survival
▪ SOK – 53%
▪ EBK – 64%
▪ Adult SCD – 57%
▪ Adult ECD – 40%
Pelletier [11] 1993–2002 2449 < 20 kg 5-year graft survival HR 0.96 for GL per
1 kg increase in
donor weight
▪ SOK – 55%
▪ EBK – 73%
Bresnahan [12] 1988–1995 2198 0–5 years 1-year graft survival SOK+ EBK GT rate 10%
▪ SOK+ EBK – 74%
5-year graft survival
▪ SOK+ EBK – 56%
Maluf [13] 2005–2010 1531 < 20 kg 1-year graft survival 1-year transplant outcomes
by kg weight strata▪ SOK – 69% (8 Kg)
▪ EBK – 80% (8 Kg)
▪ SOK – 86% (20 Kg)
▪ EBK – 91% (20 Kg)
Chesnaye [14] 1990–2013 429 0–5 years 5-year graft survival Association of donor-recipient
age combination on outcomes▪ 70% (recipient age 0–3 years)
▪ 75% (recipient age 0–5 years)
▪ 81% (recipient age 6–11 years)
▪ 83% (recipient age 12–19 years)
Yaffe [15] 1996–2013 167 10–20 kg 1-year graft survival All into paediatric recipients
▪ SOK – 90%
▪ EBK – 86%
5-year graft survival
▪ SOK – 61%
▪ EBK – 73%
Winnicki [16] 2000–2013 126 Not defined 1-year graft survival All into paediatric recipients
▪ EBK – 86%
▪ Adult SCD – 93%
5-year graft survival
▪ EBK – 64%
▪ Adult SCD – 69%
Diaz [17] 1990–2012 100 Not defined 12-year graft survival GT rate 15%
▪ EBK – 79%
▪ Adult SCD – 69%
Satterthwaite [18] 1984–1995 91 1–4 years 1-year graft survival
▪ SOK – 64%
▪ EBK – 82%
Thomusch [19] 1989–2008 78 Not defined 1-year graft survival
▪ EBK – 83%
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Table 2 (continued)
Author Date range n = x Definition of SPD Outcome – graft survival Comments
▪ Adult SCD – 90%
5-year graft survival
▪ EBK – 76%
▪ Adult SCD – 78%
10-year graft survival
▪ EBK – 74%
▪ Adult SCD – 56%
Sureshkumar [20] 1990–2001 72 Not defined 1-year graft survival GT rate 13% - Mean
age 17 months▪ EBK – 82%
▪ Adult LD – 93%
Gander [21] 2000–2015 60 0–6 years 1-year graft survival
▪ All SPD organs – 1 year. GS 81%
5-year graft survival
▪ All SPD organs – 5 years. GS 70%
Strey [22] 1992–1999 56 0.50.5–48 months 1-year graft survival GT rate 21% - donors < 1 years
age (heparinisation used)▪ EBK – 78%
▪ Adult DD – 92%
Sharma [23] 2000–2011 52 < 10 years old 5-year graft survival All into adult recipients
▪ SOK – 81%
▪ EBK – 94%
▪ Adult SCD – 75%
▪ Adult ECD – 75%
Borboroglu [24] 1994–2001 48 0–2 years 2-year graft survival
▪ SOK – 93%
▪ EBK – 77%
Dave [5] 1997–2011 47 < 2 years 1-year graft survival No difference compared to older
paediatric donors. Median
9 years. PS 100%
▪ SOK+ EBK – 83%
Bretan [25] 1993–1996 40 0–5 years 1-year graft survival GT rate 2.5%
▪ EBK – 100%
2-year graft survival
▪ EBK – 85%
Sui [26] 2012–2014 38 < 15 kg 1-year graft survival All into paediatric recipients
▪ All SPD organs – 89%
▪ SOK – 96%
▪ EBK – 70%
Basiri [27] 2006–2013 36 Not defined 1-year graft survival GT rate 5.5%
▪ EBK+ SOK – 90%
▪ Adult DD – 92%
Hobart [28] 1990–1997 33 < 4 years 1-year graft survival GT rate 15%
▪ EBK – 87%
▪ Adult DD – 84%
Mohanka [29] 2002–2006 33 < 15 kg 1-year graft survival All into adult recipients
▪ SOK – 86%
▪ EBK – 79%
Salvatierra [30] 1969–1973 32 1–9 years 6-month graft survival
▪ SOK – 50%
Zafarghandi [31] 2004–2009 23 < 16 years 1-year graft survival All into adult recipients
▪ EBK+ SOK – 96%
▪ Adult DD – 91%
5-year graft survival
▪ EBK+ SOK – 85%
▪ Adult DD – 85%
GS graft survival,GT graft thrombosis,HR hazard ratio,GL graft loss, LD live donor,DD deceased donor, SOK single organ kidney,EBK en bloc kidney,
PS patient survival
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outcomes, with EBK transplantation associated with the best
long-term graft and patient survival. Similarly, Pelletier et al.
analysed 2449 recipients of SPD kidneys [11]. Graft survival
for the EBK transplant groups was superior than that of single
kidney transplantation (73% vs 55%), with a hazard ratio of 0.96
for every kilogramme increase in donor weight. Satterthwaite
et al. in a single-centre review examined the use of kidneys from
very young deceased donors (under 4 years old), demonstrating
better graft survival following EBK transplantation, with 1- and
5-year graft survival of 82% and 70% respectively [18].
Recipients undergoing single kidney transplantation exhibited
1- and 5-year graft survival of 64% and 40%. However, the
authors noted that kidneys from donors less than 2 years had
poorer long-term outcomes, irrespective of the technique used.
Mitrou et al. have also examined outcomes following EBK
transplantation of very small kidneys from infant donors (body
weight < 10 kg) [32]. The authors identified 28 EBK transplant
recipients, of which 11 were from donors weighing less than
10 kg. Serum creatinine at 1, 3 and 5 years was similar between
small and large donors (donor weighing > 10 kg) groups.
Interestingly, both groups exhibited marked volumetric growth
within the first year of follow-up. At the time of transplantation,
grafts from the smaller donors were significantly smaller
(28 ± 9 mm3 vs 45 ± 12 mm3, p < 0.01); however, at 1-year
post-transplantation, the graft sizes from both groups were sim-
ilar (88 ± 44 mm3 vs 93 ± 52 mm3, p =NS).
Whilst these results are encouraging, there still exist a pau-
city of strong evidence of the long-term outcomes and the fea-
sibility of utilising kidneys from infant donors. Several investi-
gators have suggested that there may be a lower age threshold,
beyond which results are inferior [25, 33]. However, much of
this commentary is based on historical data and further analysis
of contemporary practice and outcomes is needed.
There is compelling evidence to suggest that overall EBK
transplantation provides excellent graft survival and function.
However, to maximise the utilisation of a scarce resource and
extend access to the benefits of transplantation to as many
recipients as possible, the question remains as to whether sin-
gle kidney transplantation to two recipients is more appropri-
ate. Laurence et al. constructed a decision analysis model to
predict the outcome in life years for patients on the transplant
waiting list depending on whether they received an EBK or
single kidney transplant [34]. The authors identified a greater
net gain in overall life years performing single kidney trans-
plantation as the technique yields two recipients per donor,
which compensated for the reduced long-term graft survival
and function. The investigators also confirmed that single kid-
ney transplant technique resulted in a net loss of life years for
donors weighing less than 10 kg. At this threshold, the inferior
outcomes from single kidney transplantation are not compen-
sated for by the generation of twice the number of recipients.
Whilst the inference may be that EBK transplantation is the
optimal technique for very small kidneys from donors
weighing less than 10 kg, the study was not able to draw firm
conclusions to confirm this.
Use of SPD organs in paediatric recipients
To expand the donor pool and decrease waiting times, there
has been increased utilisation of SPD organs transplanted into
adult recipients, with the very small organs transplanted en
bloc. Although an increased risk of graft thrombosis and
hyperfiltration injury has been demonstrated with the use of
EBK transplants, reports in adult recipients show excellent
outcomes. Currently, only a small percentage of renal trans-
plantation in paediatric recipients utilise SPDs. Children un-
dergoing renal transplantation pre-emptively or after a short
waiting time have not only survival benefit but also better
growth and cognitive development compared with children
receiving dialysis. Therefore, expanding the donor pool in
the paediatric population is of paramount importance to enable
transplantation as soon as possible in this cohort.
The large US-based registry reviews previously described
analyse long-term outcomes in combined adult and paediatric
recipient groups; none however perform sub-group analysis to
assess the outcomes of using SPD kidneys in paediatric recip-
ients [9–12]. Studies analysing long-term outcomes of SPD
kidney transplants in paediatric recipients are largely single-
centre and low-volume analyses; however, several recent larger
studies have demonstrated promising results. Winnicki et al.,
using UNOS-derived data, assessed the outcomes of 126 pae-
diatric recipients that had undergone EBK transplantation from
SPDs, comparing to paediatric recipients that had undergone
transplantation from adult SCDs [16]. Graft survival in the
EBK cohort was 64% at 5 years, with a hazard ratio of 1.15,
whilst adult SCD transplantation demonstrated a 5-year graft
survival of 69%. In a recent US-based registry review, Yaffe
et al. identified 167 children that had undergone transplantation
from SPD organs (both EBK and single kidney transplantation)
and 2350 children transplanted with adult SCD organs [15].
Paediatric recipients of adult SCD kidneys had the highest 1-
year graft survival (94%), with marginally inferior outcomes
noted in the EBK and single kidney cohorts (86% and 90%
respectively). The investigators noted that 5-year graft survival
of adult SCD and EBK transplantation (72.6% vs 72.8% re-
spectively) was comparably better than single kidney transplan-
tation (61%). In the study of Filler et al., outcomes of paediatric
renal transplant recipients from donors less than 6 years old
were reported and compared to those from older donors. Graft
survival was comparable in both groups at 1 year (77 vs 76%)
and 5 years (55 vs 60%) [35].
Despite these promising results, there is evidence that sug-
gests allograft function and survival are poorer when both
recipient and donor are young. Singh et al. in a univariate
analysis of 4394 transplants, showed that graft loss due to
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thrombosis was significantly higher in children less than
2 years of age compared to that in older groups (9% vs 3.5%
when recipients are older than 12) [7]. Recipients of kidneys
from donors less than 5 years old had a significantly higher
thrombosis rate than older donor groups (8.3% vs 3.2% in
donors greater than 10 years old). Bresnahan et al. demonstrat-
ed a reduced graft survival in paediatric transplant recipients
with SPD organs where the donor was less than 5 years old,
due to a high rate of complications [12]. However, graft sur-
vival from older paediatric donors was comparable to that of
adult donors.
It appears that the risk of transplantation with very small
SPD kidneys in both children and adult recipients is greatest in
the early postoperative period. However, it is clear that chil-
dren receiving organs from older paediatric donors have com-
parable or superior long-term functional outcomes compared
to those that receive adult allografts.
Use of paediatric DCD organs
The use of DCD organs in adults has become an accepted way
of recovering more organs for transplantation and has allowed
expansion of the donor pool. However, increasing acceptance
and utilisation of paediatric DCD organs remain challenging
for a variety of reasons. There exist limited experience and
comfort with transplanting such organs and few standardised
protocols for their use, due to concerns over compromised
graft survival. There is also considerable ethical and emotional
concerns surrounding the use of such organs.
Workman et al.’s recent review of data from the Organ
Procurement and Transplant Network (2001–2010) showed
a 10% decrease in the use of paediatric deceased donor solid
organs over the 10-year period [36]. During this period, only
42 paediatric DCD kidneys were transplanted into paediatric
recipients, whilst 805 paediatric DCD kidneys were
transplanted into adult recipients. The investigators make no
distinction between size of the organ or age of donor and
therefore no comment can be made on the use of SPD organs.
Vries et al., in a Dutch multi-centre retrospective review, iden-
tified 91 adult recipients that were transplanted with paediatric
DCD kidneys, where outcomes were compared to a larger
(n = 405) cohort of paediatric DBD organ recipients [37].
The authors showed the DCD cohort to have a higher primary
nonfunction rate (9% vs 2% respectively) and higher delayed
graft function (DGF) rate (48% vs 8% respectively) than the
DBD cohort. Estimated GFR at 1 year was comparable be-
tween the DCD and DBD groups (57 mL/min vs 58 mL/min,
respectively) and similar at 5 years (62 mL/min vs 57mL/min,
respectively) in those with functioning grafts.
In contrast to similar studies examining DCD paediatric
transplantation, Vries et al. identified that 12% of the DCD
kidneys within their analysis were considered Maastricht
category 2, defined as uncontrolled donation following unsuc-
cessful resuscitation [37]. The authors did not however in-
clude a sub-group analysis to differentiate the outcomes be-
tween uncontrolled and controlled donations. Uncontrolled
donation refers to donors who suffer an unexpected cardiac
arrest and are either brought into hospital dead (Maastricht
category 1) or when death is declared in hospital following
unsuccessful attempts at cardiopulmonary resuscitation
(Maastricht category 2).
Dion et al. in a recent single-centre analysis identified 21
adult recipients of EBK transplants from paediatric donors
under the age of 4 years old, of which four organ pairs were
obtained from DCD donors [38]. DGF ensued in 2 of 4 DCD
organ recipients and 3 of 17 DBD organs. Graft function at
1 year was comparable with GFR of 80.7 mL/min in the DCD
cohort and 85.7 mL/min in the DBD cohort. No grafts were
lost due to thrombosis during the follow-up period. Abt et al.
reviewed the UNOS database and published a review of 4026
renal transplants in paediatric recipients [39]. They identified
26 (0.6%) transplants that used DCD donors. Of the DCD
donors, 10 were from paediatric donors and the remaining
from adult donors. The authors demonstrated graft survival
at 1 and 5 years in the entire DCD group (83% and 74%
respectively) and in the DBD group (90% and 74% respec-
tively). However, the investigators did not perform sub-group
analyses on the DCD group, to compare paediatric versus
adult donors.
At present, therefore, there is minimal data regarding the
use of small paediatric DCD organs in children. Whilst results
obtained from adult DCD organs, when implanted into adults,
are equivalent to those fromDBD organs, a recent UK registry
data analysis has demonstrated that adult DCD organs, when
transplanted into children, possess outcomes that are compa-
rable to DBD organs or organs from live donors [40].
However, the higher rates of delayed graft function, the po-
tential impact of additional warm ischaemia on rejection rates
and the increased risk of early graft thrombosis in small kid-
neys means that the use of DCD organs from SPDs should be
done with care, until adequate data is available. To gain a
wider acceptance of the use of small paediatric DCD kidneys
for transplantation, there is a need for greater assessment of
long-term graft function and survival, and this needs to be
optimised for younger recipients.
Discussion
Kidney transplantation is the treatment of choice for children
with end stage renal disease. It is well established that patient
survival, quality of life, growth and cognitive development are
superior with transplantation compared to dialysis [41]. As
donor demographics change, with poorer quality deceased
donor kidneys on offer and rates of live donation falling,
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additional stratagems are being sought to expand the donor
pool. The use of small paediatric donor kidneys is now being
considered for both adult and paediatric recipients. Efforts to
reduce waiting times in the adult population have resulted in
increased acceptance of the use of SPD kidneys in adult re-
cipients, such that greater than half of all major US transplant
centres are actively performing either EBK or single kidney
transplants [13]. A number of large national registry reviews
have shown excellent outcomes with both EBK and single
kidney transplantation in adult recipients, with graft survival
and function either comparable or superior to those of SCD
and ECD transplantation. Currently, only a small percentage
of EBK transplants are performed in paediatric recipients, and
as a result there are limited studies demonstrating long-term
outcomes. Several small and single-centre reviews have been
published, which demonstrate promising results; furthermore,
two recent large US-based registry reviews have examined
long-term outcomes after transplantation with SPD organs in
children. Yaffe et al. and Winnicki et al. both demonstrated
marginally inferior outcomes in SPD organs at 1-year follow-
up compared to adult SCD organs; however, this had
equalised by follow-up at 5 years with comparable survival
rates between organ types and techniques [15, 16]. Winnicki
et al. also showed that after adjusting for co-variates, the hazard
ratio for graft failure of EBK transplantation was similar to that
of SCD transplantation 1.04 (95% CI, 0.71–1.51; p = 0.85),
whilst the EBK transplantation group had significantly shorter
wait times, between activation and transplantation, compared
to that of the SCD group (157 days vs 208 days, p = 0.03).
Historically, there has been reluctance to transplant SPD
organs in children, due to concerns of a higher incidence in
surgical complications; however, the more recent published re-
views have shown lower complication rates [5, 16]. This is
likely a result of increased experience in EBK transplantation,
shorter cold ischaemia times, increasing use of antithymocyte
globulin at induction, technical refinements and the combined
post-operative use of heparin and antiplatelet agents. These
factors suggest that EBK transplantation is a safe and feasible
option, offering superior graft and patient survival characteris-
tics in children. Further investigation is required to assess longer
outcome (> 10 years) of EBK and single kidney transplantation
in children, along with assessing the risk of hyperfiltration in-
jury and the feasibility of the potential use of DCD kidneys.
National and locally led strategies are needed to reduce
paediatric transplant waiting times and increase the deceased
donor pool by greater utilisation of SPD organs. Improved
utilisation requires tackling several weaknesses in the organ
transplant pathway. SPD organ procurement rates are low and
whilst potential causal agents have been considered, specific
rationales have not been analysed and documented [11, 36,
42]. This needs greater consideration with strategic implemen-
tation at a national organisational level (i.e. UNOS, NHSBT).
Secondly, many retrieved kidneys are discarded at either
retrieval or recipient site. Concerns regarding organ function
and potential mismatches, donor medical history and
recipient-related issues tend to result in declined organs in a
small number of cases. However, the dominant concerns cen-
tre around organ anatomy and damage at time of retrieval.
Retrieval surgeons should be appropriately trained and expe-
rienced to ensure that SPD organs are safely recovered. Short
cold ischaemia times and meticulous back table preparation
are of paramount importance.
Another opportunity to increase transplantation rates would
be to lower the threshold for en bloc splitting, to allow single
kidney transplantation into two different recipients. Further ev-
idence is required to determine the optimal donor weight for
single-organ kidney and EBK transplantation; however, we
would suggest a sensible minimum threshold of 15 kg when
considering single kidney transplantation from SPDs. The de-
cision to transplant organs from SPDs and the choice of
performing EBK versus single kidney transplantation require
careful consideration and assessment to ascertain that maximal
benefit is attained for individual recipients and the remaining
patients on the waiting list. When considering splitting, the
surgeon should also consider the surgical approach and poten-
tial space required in the recipient. EBK transplantation into
adult recipients within the extraperitoneal iliac fossa is well
recognised and commonly performed. A similar approach
may also be suitable in older children and adolescents; howev-
er, smaller children are likely to need an intra-peritoneal ap-
proach. In all but the smallest children, there is adequate space
to transplant small EBKs within the abdominal cavity without
developing abdominal compartment syndrome. However, there
are no models described within the literatures to determine the
available space or to stratify the risk of compartment syndrome;
the authors would therefore recommend a case by case assess-
ment by an experienced surgeon.
There is no doubt that centre volume and surgeon experi-
ence will affect graft survival rates, especially in very small
paediatric recipients. Centralising specialist services in high-
volume centres will result in better patient and graft outcomes.
In the UK, two NHS hospital trusts (Guy’s Hospital and Leeds
Hospital) have been appointed as national specialist leads for
utilisation of organs from donors below 2 years old.
Discussions are ongoing in the UK about the provision of
expertise for such retrievals. Clearly, evidence will be required
that any additional resources result in a significant benefit.
Conclusion
In conclusion, many SPD kidneys are excellent quality organs
and have the potential to significantly expand the paediatric
donor pool. These organs will allow the benefits of transplan-
tation to be extended to many children and provide good long-
term graft function, but carry an increased risk of perioperative
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thrombosis. It is likely that en bloc organs are to be preferred
for small donors, although the cut-off point is unclear.
Similarly, the minimum donor weight is uncertain, although
organs from neonates have been transplanted. Using organs
from small paediatric donors for implantation into children is
feasible, and probably offers at least equivalent outcomes to
ECD donors, but organs from very small donors should prob-
ably not be used widely until further data is available. We
advocate a careful but considered approach to the use of these
organs. We encourage stratagems to increase retrieval and
utilisation rates as well as techniques to improve long term-
outcomes from transplantation of SPD organs.
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Multiple Choice Questions (answers are provided following the reference
list)
1. The correct definition of an Extended Criteria Donor is:
a) Any donor aged ≥ 60 years old, or a donor aged between 50 to
59 years of age with at least two of the following features:
history of hypertension, terminal serum creatinine >1.5 mg/dL
(133 mmol/L), or cerebrovascular cause of death
b) Any donor aged ≥ 55 years old with at least two of the follow-
ing features: history of hypertension, terminal serum creatinine
>1.5 mg/dL (133 mmol/L), or cerebrovascular cause of death
c) Any donor aged ≥ 60 years old, or a donor aged between 50 to
59 years of age with at least two of the following features:
history of diabetes, terminal serum creatinine >1.5 mg/dL
(133 mmol/L), or cerebrovascular cause of death
d) Any donor aged ≥ 50 years old with at least two of the follow-
ing features: history of diabetes, terminal serum creatinine
>1.5 mg/dL (133 mmol/L), or cerebrovascular cause of death
2. En bloc kidney transplantation refers to:
a) The retrieval of both kidneys, with subsequent anastomoses of
each renal artery and vein to the recipient vessels
b) The retrieval of a single kidney and major blood vessels togeth-
er, with subsequent anastomoses of the donor aorta and inferior
cava to the recipient vessels
c) The retrieval of both kidneys and major blood vessels together,
with subsequent anastomoses of the donor aorta and inferior
cava to the recipient vessels
d) The retrieval of a single kidneywith subsequent anastomoses of
the renal artery and vein to the recipient aorta and inferior cava
3. Which of the following donor characteristics is NOT used in deter-
mining the Kidney Donor Profile Index (KDPI):
a) Donation after Circulatory Death (DCD) Status
b) Ethnicity
c) Cold ischaemia time
d) Serum creatinine
4. Which of the following is the most common cause of early graft loss





d) Thrombosis of donor vessels
5. The Modified Maastricht Classification for Donors after Circulatory
Death (DCD) determines the following categories as uncontrolled
donation:
a) Maastricht category I and Maastricht category II
b) Maastricht category I and Maastricht category V
c) Maastricht category II and Maastricht category III
d) Maastricht category II and Maastricht category V
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